Your SlideShare is downloading. ×
Dr chongck mers cov media briefing (pkp's slide) 5 july 2013
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Dr chongck mers cov media briefing (pkp's slide) 5 july 2013

249

Published on

Taklimat berkenaan MERS-COV (Middle East Respiratory Syndrome-Corona Virus) oleh Dr ChongCK bertarikh 5 Julai 2013 di IPK Bangsar. …

Taklimat berkenaan MERS-COV (Middle East Respiratory Syndrome-Corona Virus) oleh Dr ChongCK bertarikh 5 Julai 2013 di IPK Bangsar.

Virus ini mula tersebar di Arab Saudi, dan perhatian lebih perlu diberikan kepada jemaah-jemaah yang baru pulang dari Umrah di Makkah & Madinah, Arab Saudi.

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
249
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • Taken from CDC
  • Transcript

    • 1. Media Briefing: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Disease Control Division Ministry of Health Malaysia 5 July 2013
    • 2. Media & MERS-CoV: What Is Your Role? • Keeping the community informed about MERS-CoV, through sustained engagement with the Ministry of Health (MOH) Malaysia • Media’s social obligation to the public in providing verified information from the identified MOH sources
    • 3. Overview of MERS-CoV: • New strain of coronavirus that has not been seen in humans before • Coronaviruses are a large family of viruses that cause illness in humans and animals • SARS-CoV (2003) is distantly related to MERS-CoV • UNKNOWN: – Source of infection? – Mechanism of transmission? – Widespread of infection? – Clinical pattern and course of the disease? • Presenting symptoms: acute, severe respiratory illness • No specific treatment for the disease and should be based on the patient’s symptoms • No vaccine is currently available
    • 4. MERS-CoV Cases and Deaths: April 2012 – June 2013 Countries Cases (Deaths) France 2 (1) Italy 3 (0) Jordan 2 (2) Qatar 2 (0) Saudi Arabia 62 (34) Tunisia 2 (0) United Kingdom (UK) 3 (2) United Arab Emirates (UAE) 1 (1) TOTAL 77 (40) WHO does not recommend any travel or trade restrictions with respect to MERS-CoV
    • 5. Malaysia & MERS-CoV: The Preparedness Activities • Dissemination of information to the public and the healthcare community • Management of Malaysian hajj / umrah pilgrims • Screening of travellers and flight crews at the international points of entry • Surveillance of respiratory illness i.e. clinical-based and laboratory based surveillance • Management of respiratory illness  Clinical management of the patients  Laboratory management of the clinical samples
    • 6. “The future of humanity and microbs likely will unfold as episodes of a suspense thriller that could be titled Our Wits Versus Their Genes” Dr. Joshua Lederberg ˜ THANK YOU ˜
    • 7. “The future of humanity and microbs likely will unfold as episodes of a suspense thriller that could be titled Our Wits Versus Their Genes” Dr. Joshua Lederberg ˜ THANK YOU ˜

    ×